知镜 Cognispect · 医学文献与研究工作台

Real-World Safety of Concomitant Colchicine and Statin Therapy.

Meidan R, Loutati R, Caspi D, Elkayam O, Abuhasira R, Eviatar T.
Arthritis care & research · 2026-09-28 · PMID 42803209

文献摘要

Objective This study aimed to evaluate the risk of clinically meaningful muscle- and liver-related outcomes associated with concomitant colchicine-statin therapy in a real-world setting, and to determine whether concomitant therapy increases the incidence of toxicity compared with either agent alone. Methods This was a retrospective cohort study using the national Clalit Health Services database (≈5.4 million insured individuals). Adults with gout or familial Mediterranean fever between 2010 and 2024 were categorized into four exposure groups: no treatment, colchicine only, statin only, or concomitant therapy. Propensity-score matching was used to balance baseline characteristics. The primary outcome was creatine kinase (CK) elevation >3× the upper limit of normal (ULN), and secondary outcomes included alanine transaminase elevation >5× the ULN, myopathy, liver disease, and hospitalizations related to these conditions. Results Eligible participants before and after propensity-score matching were 104,066 and 31,839, respectively (no treatment n = 7,146; colchicine only n = 7,146; statin only n = 9,030; concomitant therapy n = 8,517). Compared with no treatment, CK elevations >3× ULN were observed with statin therapy (hazard ratio [HR] 1.64 [95% confidence interval (CI) 1.39-1.93]) and concomitant colchicine-statin therapy (HR 1.74 [95% CI 1.44-2.09]) but not with colchicine therapy alone (HR 1.08 [95% CI 0.89-1.31]). Clinically diagnosed myopathy was infrequent and showed a graded increase across exposure groups, with the highest risk observed in the concomitant treatment group (HR 1.50 [95% CI 1.31-1.72]). Conclusion Although colchicine-statin concomitant therapy was associated with higher rates of laboratory and clinical adverse events, the additional risk beyond statin monotherapy was small, supporting their use when clinically indicated.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。